HomeCompaniesProfile

Notable Labs

Personalized drug discovery for blood cancer. 


Company Size

11 - 50 employees

Year Founded

2014


About Notable Labs

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships.

https://www.notablelabs.com/careers

Latest Jobs


Founders & Key People

Pete Quinzio

Pete Quinzio

Co-founder of Notable Labs

Matthew De

Matthew De

Co-founder of Notable Labs

Share This Profile

More Companies

DigiBuild Software

We buy & track building materials for construction companies.

Nuvocargo

Radically simplifying cross-border logistics between USA & Mexico

CareRev

Seamlessly connecting healthcare facilities and professionals through…

Insight

The first extensible browser for iOS

Aquarium Learning

We help ML teams improve their models by improving their datasets

Ramani

We're building financial infrastructure for Africa's supply chains

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.